Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThalassa (di) Regulatory News (THAL)

Share Price Information for Thalassa (di) (THAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.50
Bid: 23.00
Ask: 26.00
Change: 1.50 (6.52%)
Spread: 3.00 (13.043%)
Open: 24.50
High: 24.50
Low: 24.50
Prev. Close: 23.00
THAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Preference Shares & Amendment to Articles

4 Oct 2018 07:00

RNS Number : 9126C
Thalassa Holdings Limited
04 October 2018
 

 

Thalassa Holdings Ltd

 

(Reuters: THAL.L, Bloomberg: THAL:LN)

 

("Thalassa" or the "Company")

 

Issue of Preference Shares and

Amendment to Company's Memorandum and Articles of Association

 

 

This announcement contains inside information for the purposes of Article 7 of Regulation 596/2014.

 

The Company announces that one preference share ("Preference Share") has been issued for each ordinary share held in the capital of the Company registered in the name of a shareholder as at the record date of 30 September 2018 ("Record Date"). Further, pursuant to and in accordance with article 109 of the Company's articles of association, a resolution was passed by the directors of the Company on 1 October 2018 approving a revised memorandum and articles of association ("Amended Articles") which incorporate the rights attaching to the Preference Shares summarised below. The Amended Articles have been subsequently adopted by the Company and a copy will be available on Thalassa's website at http://thalassaholdingsltd.com/company-documents.htm.

 

Each shareholder of the Company has been issued with one Preference Share for each ordinary share held in Thalassa as at the Record Date. The key features of the Preference Shares are that (i) they are unquoted; (ii) they are uncertificated; (iii) they are non-transferable (meaning both that the Preference Share is not transferable or tradeable itself and, in the event a shareholder disposes of any ordinary share, the corresponding Preference Share will be cancelled and will not be transferred to the transferee of such ordinary share); and (iv) they are without any shareholder rights (including as to any return on a winding up or other realization event for the Company) other than so as to provide the shareholder holding such Preference Share with 10 votes per share in addition to his existing one vote per ordinary share.

 

The Amended Articles incorporate amendments to clause 7 of the memorandum of association of the Company, as well as articles 14, 18, 20, 23 and 43 to reflect the above.

 

The Company's registrar, Link Asset Services, will send a letter to each shareholder on Thalassa's register as at the Record Date confirming the issue of Preference Shares and that shareholder's entitlement to Preference Shares.

 

The Company advises that the total number of ordinary shares of the Company in issue remains at 25,567,522, including those ordinary shares held in treasury.

The total number of ordinary shares in issue (excluding those held in treasury) at the date of this RNS is 18,574,775 each with one vote. The ordinary shares retain 100% of the economic rights of the Company, both in respect of dividends, buy backs, in liquidation or any other corporate event such as the sale of the Company.

The total number of preference shares outstanding at the date of this RNS is 18,574,775 with 10 votes each but no economic value, or a total of 185,747,750 voting rights.

Total voting rights in the Company are currently 204,322,525.

The aggregate figure of 204,322,525 represents the total voting rights in the Company that may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the voting rights of the Company. The total voting right will be updated and published on a monthly basis to reflect cancellation of Preference Shares in conjunction with the sale of corresponding ordinary shares.

Contacts:

Thalassa Holdings Ltd:

 

Duncan Soukup, Executive Chairman +33 (0)6 78 63 26 89

WH Ireland Limited (Nominated adviser):

Chris Fielding, Managing Director, Corporate Finance 020 7220 1650

www.thalassaholdingsltd.com

 

Notes to Editor:

 

Thalassa Holdings Ltd, incorporated and registered in the BVI and quoted on AIM, is a holding company with various interests across a number of industries.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEZMMGGGFMGRZZ
Date   Source Headline
30th Apr 20243:40 pmEQSThalassa Holdings Ltd:
30th Apr 20243:33 pmEQSThalassa Holdings Ltd: Annual Financial Report
12th Jan 20247:36 amEQSThalassa Holdings Ltd: Trading Update
16th Nov 202312:27 pmEQSThalassa Holdings Ltd: TR1
29th Sep 20239:01 amEQSThalassa Holdings Ltd: Interim Results (30 June 2023)
28th Sep 202311:09 pmEQSThalassa Holdings Ltd: Amendment to Articles of Association
17th Jul 20238:12 amEQSThalassa Holdings Ltd: Restoration of Listing
10th Jul 202310:50 amEQSThalassa Holdings Ltd: Final Results For Year Ended 31 December 2022
30th Jun 20237:57 pmEQSThalassa Holdings Ltd: Result of AGM
7th Jun 20237:51 pmEQSThalassa Holdings Ltd: AGM Proxy Form
5th Jun 202311:20 amEQSThalassa Holdings Ltd: Notice of AGM
2nd May 20237:51 amEQSThalassa Holdings Ltd: Temporary Suspension
2nd May 20237:30 amRNSSuspension - Thalassa Holdings Ltd
19th Apr 20238:45 pmEQSAppointment of Auditor
14th Feb 20234:12 pmEQSThalassa Holdings Ltd: Confirmation of previously announced proposal
27th Jan 20233:40 pmEQSThalassa Holdings Ltd: Trading Statement
27th Jan 20232:40 pmEQSThalassa Holdings Ltd: Trading Statement
13th Dec 20227:38 pmEQSThalassa Holdings Ltd: STR-Statement re resignation of auditor
13th Dec 20226:38 pmEQSThalassa Holdings Ltd: STR-Statement re resignation of auditor
24th Oct 20228:35 amEQSThalassa Holdings Ltd: Correction
24th Oct 20228:34 amEQSThalassa Holdings Ltd: Correction
21st Oct 202211:00 amEQSThalassa Holdings Ltd: Directorate Change
21st Oct 202210:59 amEQSThalassa Holdings Ltd: Directorate Change
15th Aug 20227:01 amEQSThalassa Holdings Ltd: Interim Results
15th Aug 20227:00 amEQSThalassa Holdings Ltd: Interim Results
28th Jun 20223:47 pmEQSThalassa Holdings Ltd: Result of AGM
28th Jun 20223:47 pmEQSThalassa Holdings Ltd: Result of AGM
27th Jun 20221:03 pmEQSThalassa Holdings Ltd: Appointment of Broker
27th Jun 20221:02 pmEQSThalassa Holdings Ltd: Appointment of Broker
9th Jun 20223:37 pmEQSThalassa Holdings Ltd: Final Results for Year Ended 31 December 2021
9th Jun 20223:34 pmEQSThalassa Holdings Ltd: Final Results for Year Ended 31 December 2021
9th Jun 20223:19 pmEQSThalassa Holdings Ltd: Notice of AGM
9th Jun 20223:18 pmEQSThalassa Holdings Ltd: Notice of AGM
24th May 202211:27 amEQSThalassa Holdings Ltd: Appointment of Non-Executive Director
28th Feb 20221:37 pmEQSThalassa Holdings Ltd: Trading Statement
17th Dec 20217:17 amRNSReverse Takeover of id4 AG by Anemoi International
15th Nov 20219:01 amRNSid4 delivers Client Space solution
28th Oct 20215:00 pmRNSHolding(s) in Company
7th Oct 20213:59 pmRNSResult of AGM
28th Sep 20217:00 amRNSInterim Results
17th Sep 202112:50 pmRNSLondon Medical Laboratory investment update
30th Jul 20213:23 pmRNSProposed Transaction
22nd Jun 202110:29 amRNSFinal Results for YE 31 Dec 2020 and Notice of AGM
14th Jun 20217:00 amRNSPreliminary Results for the year ended 31 Dec 20
29th Apr 20217:01 amRNSGrant Funded Project for Autonomous Robotics Ltd
29th Apr 20217:00 amRNSNotice of Results
8th Mar 20217:00 amRNSDe-listing from Luxembourg Stock Exchange
3rd Mar 20217:00 amRNSAppointment of Chief Financial Officer
4th Feb 202111:17 amRNSThalassa subsidiary id4 wins at Swiss WB Awards
2nd Feb 20217:00 amRNSInvestment in London Medical Laboratory Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.